HSIC Henry Schein, Inc.
Healthcare$74.19+0.00%OpenMarket Cap: $8.45B
As of 2026-05-26
Valuation
P/E (TTM)
21.72
PEG
10.59
P/B
2.61
P/S
0.63
EV/EBITDA
12.13
DCF Value
$83.34
FCF Yield
5.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
29.7%
Operating Margin
5.6%
Net Margin
3.0%
ROE
11.9%
ROA
3.5%
ROIC
6.2%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $3.37B | 31.8% | $182.0M | $107.0M | $— | — |
| Q4 null | $3.44B | 28.9% | $186.0M | $101.0M | $— | — |
| FY null | $13.18B | 29.1% | $758.0M | $398.0M | $— | — |
| Q3 null | $3.34B | 28.7% | $206.0M | $101.0M | $— | — |
| Q2 null | $3.24B | 29.4% | $175.0M | $86.0M | $— | — |
| Q1 null | $3.17B | 29.6% | $202.0M | $110.0M | $— | — |
| Q4 null | $3.19B | 29.1% | $192.0M | $94.0M | $— | — |
| FY null | $12.67B | 29.7% | $729.0M | $390.0M | $— | — |
| Q3 null | $3.17B | 29.3% | $205.0M | $99.0M | $— | — |
| Q2 null | $3.14B | 30.5% | $174.0M | $104.0M | $— | — |
| Q1 null | $3.17B | 30.0% | $160.0M | $93.0M | $— | — |
| Q4 2023 | $3.02B | 28.7% | $60.0M | $18.0M | $0.14 | — |